tiprankstipranks

Paul Choi Profile - Goldman Sachs Analyst

410 Followers
tipranks
Paul Choi

Paul Choi
Goldman Sachs

Wall Street Analyst
#1,673 out of 12,278 Wall Street Analysts
#3,769 out of 28,770 experts

Success Rate

54%
141 out of 259 ratings made a profit

Average Return

+8.40%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying Paul Choi's trades since 2017 and holding each position for 1 Year would result in 54.44% of your transactions generating a profit, with an average return of 8.4% per rating.

Stock Rating Distribution

472Ratings
47.25% Buy
33.69% Hold
19.07% Sell
Distribution of Paul Choi's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United States
Hong Kong

Best Rating

Stock:
Myovant Sciences
(MYOV)
Rating:Buy
Date:Oct 25, 2019 - Oct 25, 2020
Return:+252.30%
The most profitable rating made by Paul Choi

Paul Choi's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Eli Lilly & Co
Apr 07, 2017
Buy
Reiterated
$90.00
(-92.05% Downside)
1Ratings
0%
-7.50%
Incyte
Nov 01, 2017
Buy
Reiterated
$165.00
(61.16% Upside)
2Ratings
0%
-45.45%
Nektar Therapeutics
Mar 30, 2020
Hold
Upgraded
$20.00
(-65.11% Downside)
5Ratings
50%
-6.50%
Neurocrine
Jun 29, 2020
Hold
Downgraded
$135.00
(-17.62% Downside)
4Ratings
100%
+28.67%
Odonate
Aug 24, 2020
Sell
Reiterated
2Ratings
100%
+64.60%
Array Technologies
Nov 09, 2020
Buy
Initiated
$50.00
(518.05% Upside)
1Ratings
0%
-48.60%
Dianthus Therapeutics
Mar 04, 2021
Buy
Reiterated
$17.00
(-78.88% Downside)
3Ratings
50%
-32.50%
Korro Bio
Sep 22, 2021
Hold
Downgraded
$9.00
(-16.04% Downside)
5Ratings
25%
-20.08%
Puma Biotechnology
Nov 05, 2021
Hold
Reiterated
$7.00
(-0.43% Downside)
8Ratings
75%
+10.25%
ARS Pharmaceuticals
Apr 03, 2022
Hold
Downgraded
$3.50
(-59.11% Downside)
4Ratings
0%
-78.77%
List of latest recommendations made by Paul Choi. Click to expand and see Paul Choi's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Advertisement
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

About Analyst Ratings

About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•  
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•  
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•  
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.

Paul Choi activity FAQ

What is the performance of Paul Choi's recommendations?
The percentage of profitable recommendations made by Paul Choi is 54%, and the average return per transaction is 8.40%.
    What stocks does Paul Choi cover?
    Paul Choi mostly covers BBIO ,AMRN ,VIR stocks.
      What was Paul Choi's most profitable rating?
      Paul Choi’s most profitable ratings was a buy on MYOV stock on Oct 25, 2019 - Oct 25, 2020. The return on the trade was +252.30%.
        Where can I see a list of stock analyst ratings?
        You can see a list of daily stock analyst ratings here.
          What are the most recommended stocks by analysts?
          You can see a list of the most recommended stocks by analysts here